Home

Ramtin Agah, Chief Medical Officer: RenovoRx RNXT Buy · Filed 25/12/17

Trade details

Type
Insider buy
Amount
$10,200
Shares · price
12,000 sh · $0.85 a share
Held after
778,460 sh
Trade date
25/12/16
Filed
25/12/17
Days to filing
1 days

First buy since 2023

Insiders buying this week
2 insiders
Holding change
+1.6%

RenovoRx trades, last 26 weeks

What else happened in RenovoRx around then

Filed or reported within 30 days of the trade day · 25/11/16~01/15

Ramtin Agah's recent trades

  • Ramtin Agah

    BuyRenovoRx

    $10K

    Filed 01/22

  • Ramtin Agah

    BuyRenovoRx

    $8,424

    Filed 01/05

  • Ramtin Agah

    BuyRenovoRx

    $170

    Filed 01/02

  • Ramtin Agah

    BuyRenovoRx

    $9,600

    Filed 25/12/08

  • Ramtin Agah

    BuyRenovoRx

    $9,600

    Filed 25/11/24